Humanoid supply chain

The closest thing to a monopoly on the list. Strain wave gears are the compact, zero-backlash gearboxes inside precision joints, and there is no substitute at volume. The ~85% share claim is consistent with how the market is generally described, and the humanoid order book is real but still small: roughly ¥2.5bn of humanoid-related orders guided for FY3/26, which management has suggested could double or triple in FY3/27.

The catch is that today's profit does not come from humanoids. FY3/26 landed at ¥59.6bn revenue (+7.0%) with operating profit down 94.4% year on year. The recovery is now visible, though: April–June revenue of ¥16.68bn (+23.6%) and operating profit of ¥1.84bn against ¥122m a year earlier, on consolidated orders of ¥24.13bn (+55.7%) — roughly ¥3bn of which was a one-off North American surgical-robot order. On 7 August the company lifted FY3/27 guidance to ¥74.5bn revenue and ¥8.5bn operating profit, from ¥68bn and ¥6.2bn. The stock is still priced on that forecast rather than on trailing numbers.

WatchQuarterly humanoid order disclosure. This is the single number that justifies the multiple, and nothing has been published since the 7 August guidance upgrade, which is already priced. The tape has now run eleven sessions from the 4 September close of ¥5,730: +5.5%, +4.2%, −4.5%, +2.1%, +2.7%, −3.2%, +0.7%, +0.3%, +2.1%, 0.0%, then +3.9% to ¥6,200 on the Bank of Japan's rate decision. Tokyo then shut for three sessions, and the twelfth came on the reopen: +2.4% to ¥6,350 on 24 September, its highest close since 17 August and 10.8% above where the run started. The thirteenth ended it, and quietly: −0.8% to ¥6,300 on 25 September, on a session the Nikkei rose 1.30% — so the stock gave up two points of relative ground without a word from the company, having gained two or three the day before on the same silence. The fourteenth took it back and then some: +1.6% to ¥6,400 on 28 September, its highest close since 17 August, on a day the index fell 0.73% and the name two rows below it closed limit-down. None of the run came from the order book. Two figures in this row have moved a long way on the calendar rather than on the tape, and both need reading carefully. The month reads +12.2% against +0.2% a fortnight ago, because the 30-day base has rolled onto 28 August's ¥5,750, from the ¥5,960 of 18 August. And the twelve-month column fell from +116.9% to +95.9% on 18 September, because 18 September 2025's +15.0% day dropped out of the window — then jumped to +123.0% on 24 September, twenty-seven points on a 2.4% session, because a three-day holiday rolls the base six calendar days in one step, onto 24 September 2025's ¥2,847, ten per cent below the ¥3,165 it replaced. A fifteenth session added 0.8% to ¥6,450 on 29 September, a fresh high since 17 August on a day the index fell 0.60%, so a point and a half of relative gain on the same silence. The sixteenth gave a little of it back: −0.5% to ¥6,420 on 30 September, on a session the Nikkei rose 1.94% — two and a half points of relative ground surrendered, again with nothing published. Sixteen sessions, ¥5,730 to ¥6,420, and not one of them an order disclosure. The twelve-month column turned on its base for a fifth consecutive run and this time in the opposite direction: +142.5%, three points lower on a half-point session, because the year-ago base rolled up 0.8% onto 30 September 2025's ¥2,647 after four runs of rolling down. Read it against its own date rather than as news. The drawdown is the figure no base can flatter, and it widened a third of a point with the price to 29.8%, from the 29.5% that was the tightest of the run.

The heavy-duty counterpart: cycloidal RV reducers for medium-to-large joints, with roughly 60% global share. Of the six, this is the one where the cited financials check out cleanly — FY2025 delivered ¥307.9bn revenue (+9.8%) and ¥20.7bn operating profit (+60.3%), with FY2026 guided to ¥327bn and ¥27.7bn.

Crucially, Nabtesco is committing capital ahead of the demand: it is doubling RV-reducer capacity into 2026 and bought Slovak cycloidal maker Spinea in 2023. That is a company acting on the thesis, not just narrating it.

WatchUtilisation of the doubled capacity. Idle new capacity turns a margin story into a fixed-cost problem quickly. It has been the most volatile name on the tier, and has now gone quiet: −5.7% on 2 September, then +1.6%, +1.4% and +3.6%, then −6.1% on 8 September and +4.5% on 9 September — and since then −0.7%, −1.3%, −0.3% and +0.2% — four sessions inside 1.5% after a fortnight of violent ones — before +2.6% to ¥4,551 on 16 September, its best session since 9 September, then +0.7% to ¥4,581 and +0.8% to ¥4,619 on 18 September — three gains running — and, after the three-day holiday, a fourth: +3.0% to ¥4,759 on 24 September, its best session since 9 September. A fifth followed, +0.7% to ¥4,792 on 25 September, then the streak broke at −0.2% and resumed at +0.3%, and then the largest session of the sequence arrived on the last day of the quarter: +2.6% to ¥4,919 on 30 September, its highest close since 17 August and its best session since 24 September, on an index up 1.94%, so for once the move is market rather than name, and the name still led it by seven tenths. Eight of the last ten sessions higher is the longest run this name has put together in the period this page has tracked, and none of it is company news. It sits 19.5% below its 52-week high, the tightest on the tier, and 6.7% higher over a month, where a fortnight ago that figure was 3.2% lower. Read that reversal the same way as Harmonic's: the 30-day base has rolled onto 31 August's ¥4,611, and nothing the company said moved either number.

The most concrete commercial traction on the list. Schaeffler signed a strategic partnership with Swiss Hexagon Robotics in April 2026 for strain wave and planetary gear actuators, and a separate technology and supply partnership with UK-based Humanoid. It is also a customer: it plans to deploy at least a thousand Hexagon robots across its own plants within seven years.

The in-house manufacturing point is fair — motors, power electronics and encoders are built internally. The offset is that Schaeffler remains predominantly an automotive supplier, so a humanoid win is diluted by a large, cyclical, structurally pressured base business. That mixed identity shows in the tape: down 23.4% YTD despite being up 12.0% over twelve months, and 46.6% below its high, the widest drawdown anywhere on this page. The fortnight of going nowhere ended on Friday. Four sessions had sat inside nine cents — €7.34 on 7 September, €7.43 on 8 September, €7.40 on 9 September and €7.34 on 10 September — and then 11 September broke the range, −2.0% to €7.19, the lowest close since 2 September. Monday went further, −3.3% to €6.95, and Tuesday further again: −2.4% to €6.78, the lowest close since 20 March — nearly six months undone in three sessions. Wednesday halted it, +1.2% to €6.86, the only tier-one name to rise that session, and Thursday reversed harder, +3.1% to €7.07 — its best session since 2 September. That did not hold either: −2.0% to €6.93 on 18 September, then +0.9% to €6.99 on 21 September and +2.0% to €7.13 on 22 September, its best close in a week — before giving it back, −2.2% to €6.97 on 23 September, in the same dollar-led metals session that took the minerals tier down. Then 24 September broke the whole range: −6.2% to €6.54, its worst session since 31 July and its lowest close since 26 November 2025. The sector context does not cover it — the DAX fell 0.57% with autos the worst-performing corner, and the largest carmakers in that move fell 2.2–2.4% — and there was no company disclosure on the day. The shape argues against a single headline: no gap at the open, a slow grind from €6.84 to €6.75 by mid-morning, then an acceleration through the last ninety minutes on 1.33m shares, more than three times Monday's volume. What there was, and what this page missed for two days, is a sell-side catalyst one session old: Jefferies cut its target to €8.70 from €9.45 on 23 September, keeping a Buy, with analyst Vanessa Jeffriess writing that Schaeffler's reduction of its own 2028 targets had damaged credibility — while calling the non-automotive robotics business the most attractive investment story in the sector. That note is the documented cause of the −2.2% on 23 September, which this page had loosely hung on a dollar-led metals session a German auto-parts supplier has no business being in. It does not by itself carry a 6.2% second-day move, and no disclosure does, so the caution stands — but “a cause it cannot source” was too strong: the two sessions together are −8.3%, €7.13 to €6.54, and the first of them has a name on it. It never joined the mid-August drawdown, so for a fortnight it had nothing to give back; it has given back far more than that since, and the month now reads 15.0% lower where three weeks earlier this was the one tier-one name essentially flat on that measure. Two quiet sessions have extended it rather than ended it: −2.6% to €6.46 on 28 September and −0.9% to €6.40 on 29 September, the lowest close since 21 November 2025, with nothing published on either day. Note what it is not: a chip name. Schaeffler fell on the same session as the semiconductor selloff but for its own reasons, and at 0.59 to the robotics basket it is one of the two loosest fits on the tier, alongside Ambarella at 0.54 — the two names here that are really something else. Several of these closes were reconstructed from the closing auction print when the German daily feed swallowed the session, and the ledger keeps closing behind itself: the 7, 16, 21, 22 and 23 September bars have all filled at exactly €7.34, €6.86, €6.99, €7.13 and €6.97, the last of them a fifteenth reconstruction confirmed to the cent. 24 September is the new hole, and because it carries a 6.2% session rather than a quiet one it was closed on four routes rather than two: the 17:35 auction bar at €6.54 on 484,271 shares, previousClose and chartPreviousClose both reading the same, and an independent German quote service carrying the session at 6.540. See the method note.

One correction worth flagging, because it changes the read. Measured on the thin SFFLY ADR, Schaeffler's correlation to the robotics basket looks like 0.16 — essentially unrelated. Measured on the liquid Xetra line it is 0.59. The ADR was not tracking the company; it was tracking its own illiquidity. Schaeffler belongs firmly inside the robotics bloc — and at 0.45 it is also the tier-one name that moves most with REMX, which fits a supplier whose bill of materials is heavy in magnets and bearing steel.

WatchWhether actuators are ever broken out as a reported segment. Until then the robotics revenue is invisible inside an auto-parts P&L.

The world's largest electric motor maker, building integrated humanoid motion units that fold motor, gearbox and controller together — FLEXWAVE strain-wave reducers, KINEX cycloidal gearboxes and planetary systems shown at Automate 2026. The scale argument is real: roughly ¥2.6 trillion in annual revenue (about $17bn, not $2.6tn as the post's garbled phrasing implies).

This is the one name carrying a governance problem rather than just an execution problem, and on 4 September 2026 one half of it was finally published. Nidec disclosed the Investigation Committee's report on the quality strand, received on 2 September and released once confidentiality review was complete, together with its recurrence-prevention measures. The committee, established in May 2026, found a series of quality-related failures: 4M change-rule violations, falsification and fabrication of testing and inspection results, work outside approved inspection and manufacturing conditions, the use and shipment of substandard and unauthorised items, and breaches of record preparation and management rules, arising from an “unhealthy state” of excessive cost-reduction pressure, inefficient risk monitoring and inadequate quality-assurance resourcing. The decisive line for holders is financial: Nidec's evaluation of the individual matters found no material impact on its consolidated financial statements. Remediation gives quality managers authority to suspend shipments, revises reporting lines, adds permanent complaint boxes, puts every executive and employee through quality-compliance training and starts continuous quality audits; disciplinary action is promised but nobody is named. The stock rose 5.7% on the day and a further 7.7% on the Monday after it, to ¥2,812, before losing 3.2% to ¥2,722 and a further 4.8% to ¥2,591 — giving the whole post-report rally back by Wednesday — then taking most of it straight back with +5.6% to ¥2,737 on 10 September, the largest single gain anywhere on this page, and easing 1.7% to ¥2,691 on 11 September, a further 1.3% to ¥2,655 on 14 September, then 0.5% to ¥2,642, +0.2% to ¥2,646 on 16 September, +2.9% to ¥2,724 on 17 September, and +4.8% to ¥2,856 on 18 September on the Bank of Japan's hike — the largest single gain anywhere on this page in this period, and its highest close since 4 June. The report landed on 4 September with the stock up 5.7% that session; of the ten sessions since, seven moved more than 1.3% in one direction or the other — +7.7%, −3.2%, −4.8%, +5.6%, −1.7%, −1.3%, −0.5%, +0.2%, +2.9% and +4.8% — with a three-session lull in the middle that lasted exactly as long as it took the market to find a new reason. That reading rested on an empty disclosure record, and the record is not empty. On 10 September — the same session the stock rose 5.6%, the largest single gain anywhere on this page — Nidec disclosed that a shareholder had begun a derivative action against two former directors the day before. This page's line that Nidec had disclosed nothing at all since 4 September was accurate when written and stopped being accurate on 10 September; it was repeated for fifteen days after that, and the claim audit now carries it. The narrower statement that survives is that nothing has been disclosed on the filing strand since 4 September, and that the moves since have come from interpretation rather than information — including on the day the suit became public, which the tape did not mark at all. Everything else is still open — though it is worth being precise about what "open" means, because this page previously was not. The separate third-party committee on the accounting irregularities has finished: appointed in September 2025, it delivered a mid-term report on 27 February 2026 and its final report on 17 April 2026. What outlasts the inquiry is its consequence. Nidec is still correcting accounts back to the year ended March 2022, has not closed FY3/26, and has repeatedly postponed results — including the April–June quarter, delayed again on 5 Aug 2026. A tariff strand runs alongside: additional customs duties from declaration errors were estimated in March 2026 at US$69.7m, about ¥11.14bn, including interest. The quality strand covers changes to materials, processes and designs made without customer approval, mishandled inspection data and mislabelled production locations, and on 5 August an individual shareholder formally requested that the company pursue liability against current and former directors. A second, larger request followed: on 20 August multiple shareholders jointly demanded the same action under Article 847 of the Companies Act, disclosed the next day. Those were demands that the company sue, and they concern the quality and accounting conduct. What was filed on 9 September is a different instrument and the first claim in this saga that carries a number: an individual shareholder sued two former directors — founder Shigenobu Nagamori and Hiroshi Kobe — in the Kyoto District Court (case 1749 of 2026) for ¥28,730,558,300 plus delinquent charges under Article 462, paragraph 1, the capital-maintenance provision rather than the duty-of-care one. The claim is that three specific capital returns exceeded the distributable amount: the treasury-share buybacks of September 2022 and February–March 2023, and the December 2022 midterm dividend. That is the restatement arriving as a liability instead of as an accounting entry, and it is the mechanism worth understanding — correct the accounts for those years downward and the distributable amount shrinks retroactively, which is what makes capital already paid out unlawful after the fact. Nidec says the action, being against individuals, will not affect its business performance. That is accurate about the P&L and beside the point about governance: the suit does not need to succeed to establish that the restatement has consequences with numbers attached, and ¥28.7bn is the first one. Nidec has an Executive Responsibility Investigation Committee, running since 13 March 2026, to decide whether directors, auditors and executive officers bear legal liability. The US ADR has barely traded since February, which is why the Tokyo line is the only usable quote.

Watch30 September 2026, and it is now two days out, with the stock limit-down on a report of what the filing will contain. The quality strand is closed; the accounting strand is not, and it has a hard date on it. Nidec obtained approval on 30 June to extend the filing deadline for its annual securities report for the year ended March 2026 from 30 June to 30 September — so the restatement the company has been working through since September 2025 is either filed inside three days or the extension itself becomes the story. The April–June quarter behind it is still missing too. Until both are current, position sizing here remains a governance decision rather than a robotics one. A third strand is now live alongside them: the 9 September derivative action over the 2022–23 buybacks and dividend, which turns on what the restated distributable amount actually is — so the filing due on 30 September is also the document that sizes that claim. On the closed strand, the verified count is worth carrying: the 4 September report found 844 cases of quality misconduct over about a decade — mostly changes to materials and processes without customer approval, alongside falsified tests and country-of-origin mislabelling — and Nidec states no individual matter has a material impact on its financial statements. Press reporting that attaches a ¥250bn write-down to that report is conflating it with the accounting strand; the claim audit now carries this. A fourth strand opened on 28 September and it is the loudest: Diamond Online reported that morning that the retroactive impairment will be roughly ¥1tn in the year ended March 2026, and that an emergency board on 25 September resolved to dismiss president Mitsuya Kishida. Nidec confirmed that executive changes and large-scale impairment processing are under consideration and that nothing has been decided, which leaves three impairment figures in circulation from three sources — the third-party committee’s ~¥250bn in its March report, the only one in a published document; Nikkei’s several hundred billion on 15 September; and Diamond’s ¥1tn. The filing due on 30 September is what adjudicates between them, which is why the deadline now carries more than a compliance question. This page also has a standing observation to retire. Through this whole run Nidec showed the tightest drawdown on the page by a wide margin — 3.4% off a 52-week high of ¥2,941 as recently as 25 September — and this page kept noting that a stock trading that close to its high is not the same thing as a stock that has recovered, on a company whose accounts for the year ended March 2026 do not yet exist. One limit-down session settled it: −17.6% to ¥2,340, 20.4% off the high, and the twelve-month column through zero from +6.7% to −11.3%. Its twelve-month return, meanwhile, has changed sign twice inside a week, and neither move came from the company. Nidec rose 4% on 12 September 2025, and that session rolling into the comparison cut the twelve-month return from +7.5% to +2.1% on a 1.3% price move. This page then forecast the next crossing to the day — on 16 September the base became 16 September 2025’s ¥2,671, and a +0.2% session took the twelve-month number below zero, to −0.9%. One day later the base rolled again, to 17 September 2025’s ¥2,691, and a +2.9% price move put it back above zero at +1.2%. Two sign changes, two sessions, one of them driven purely by which day fell out of the window. The next session was the clean control case: the base did not move — ¥2,691 on both 17 and 18 September 2025 — so a +4.8% price move took the figure to +6.1% and nothing else did. Same column, three consecutive readings, two mechanisms. The holiday then supplied a fourth: the base rolled six calendar days at once, off ¥2,691 onto 24 September 2025's ¥2,642, so a falling session left the twelve-month figure higher, at +6.8%. It is the cleanest illustration on this page of a return figure that moves because the calendar did — and a warning about reading any twelve-month column on a date when the base is volatile. The 28 September reading is the control case for the whole sequence: the base moved by a single session, from ¥2,662.5 to ¥2,636.5, and the column fell eighteen points anyway. When the price does something like this, the calendar stops mattering. 29 September extended it on ordinary trading rather than a limit — −3.8% to ¥2,250, a fall of ¥90 against a ¥500 limit, and the lowest close since 15 April 2026 — taking the drawdown to 23.5% and the twelve-month cell to −12.1%. Then the disclosure record caught up with the news. At an extraordinary board meeting on 29 September Nidec accepted the resignation of president and chief executive Mitsuya Kishida and appointed Michio Kaida, First Senior Vice President and vice-chair of its reform committee, in his place, saying Kishida “had, on certain occasions, made statements or engaged in conduct in relation to financial reporting that could not necessarily be regarded as appropriate.” 30 September took the stock +4.7% to ¥2,355, its largest gain of this whole episode, on that plus a Nikkei report of final-stage talks to sell Nidec Components to Carlyle for more than ¥100bn: a press report, not a disclosure. The drawdown comes back to 19.9% and the twelve-month cell to −10.6%. What has not arrived is the document. The annual securities report for FY3/26 was due on 30 September, the deadline having already been extended once, and as of this compile no restated accounts and no final impairment figure have been verified from the company. That report is what settles whether the real number is the roughly ¥250bn Nidec itself put under impairment review or the ¥1tn the press has reported, and until it is read the stock is being priced on the difference.

One of very few firms that can already supply precision motion at industrial scale, now pointed at humanoids: it acquired 100% of Tokyo Robotics, whose whole-body torque sensing and impedance control fill a genuine capability gap, and ships MOTOMAN Next with NVIDIA GPUs for autonomous control.

But the profit claim in the source post is backwards. For the fiscal year ended February 2026, revenue edged up while operating profit fell more than 5%, with pre-tax and net profit down harder. The growth is in the forecast — FY2/27 guidance of ¥580bn revenue (+7%) and ¥47bn net profit (+33%). Up 46.8% over twelve months but 41.5% below its high — second only to Schaeffler now — it is the clearest example here of a stock priced on guidance rather than results. Its year-to-date return turned negative on 1 September and kept going: a 4.4% fall on 8 September wiped out three modest up sessions, a 1.6% loss on 10 September took it below its April low, a further 3.0% on 11 September took it to ¥4,301, then two yen lower on 14 September and three yen lower again on 15 September — three consecutive closes at the weakest since 3 April, and the manner of them was the point: not a capitulation but a slow bleed of two and three yen a session while the rest of the tier drifted higher. That run ended on 16 September, +1.5% to ¥4,360, its first gain in five sessions — then lasted exactly one day, −1.4% to ¥4,299 on 17 September, before the rate decision took it +2.0% to ¥4,383 on 18 September, and the reopen after the three-day holiday added +2.8% to ¥4,507 on 24 September, its highest close since 7 September. Then it gave a little back, −0.6% to ¥4,480 on 25 September — and on that session the Nikkei rose 1.30%, so this was the widest relative loss of the six Tokyo names here, nearly two points behind the index. Then it turned: −0.6% to ¥4,453 on 28 September, +1.7% to ¥4,528 on 29 September, the best of the six that day, and +2.3% to ¥4,633 on 30 September, its highest close since 7 September, on an index up 1.94%. Those three sessions took the month from 9.5% lower to 3.1% lower and the year to date from −5.8% to −2.6%, with the drawdown in to 41.5%. Note what did not change: a bounce off the weakest closes since 3 April is not the first-half number, and the guidance it is priced on does not get tested until that arrives.

WatchFirst-half progress against that +33% net profit guide. It is a forecast-driven multiple with a recent record of missing.

The only US-listed name and the only one with a clean, current, verifiable set of numbers. CV7 launched at CES on 5 January 2026 — an 8K edge AI vision SoC for multi-sensor perception across robotics, drones, industrial automation and automotive. Fiscal 2026 revenue was $390.7m, up 37.2%, with fiscal 2027 growth guided at 10–15%. Q2 FY2027, reported on 3 September, came in at $108.1m (+13.2%) with non-GAAP EPS of $0.18 — both a shade ahead of consensus — and Q3 guided to $115–124m.

The robotics pipeline is disclosed rather than implied: 15+ robotics design wins with lifetime revenue above $100m, and 30+ customers in the pipeline. The honest caveat is that robotics is still the smaller part of a business anchored in security cameras and automotive — and the deceleration from +37% to a guided 10–15% is the number bulls have to explain.

Nor did the follow-up. Fermi Wang appeared at Citi's Global TMT Conference on 9 September and was blunter there than on the call: robotics has “a couple design wins,” but the volume is not going to change the financial performance materially, and humanoids are, on his account, harder from a technology standpoint than a level-5 autonomous car. He also named the constraint that is not in the guidance — memory. Customers, he said, could not get allocation commitments from their memory suppliers even for November, which he called the biggest uncertainty and expected to run into 2027. For a fabless designer that is a customer-side supply problem, not a demand one, but it lands on the same revenue line.

The Q2 call moved the narrative without moving the disclosure. Fermi Wang said edge AI revenue “reached record levels” on balanced sequential growth in Auto and IoT and very strong growth from the 5nm CV75 and CV72 SoCs, and the company raised its five-year serviceable-market forecast for edge AI and physical AI, citing higher-value products and new distribution through Macnica and CapGemini. Margins went the other way: non-GAAP gross margin of 59.3% against 60.5% a year earlier, with the Q3 guide at 59–60%. Still a GAAP loss — $6.7m, or $0.15 a share — against $8.2m of non-GAAP net income, on $272.3m of cash.

WatchRobotics revenue disclosed as its own line — and Q2 did not do it. “Physical AI” now appears in the serviceable-market framing, but there is still no robotics number to hold anyone to, so this name remains a narrative read rather than a volume read. Then the tape did something the disclosure did not explain. Ambarella rose 8.4% to $68.80 on 9 September, the largest single move on this page in weeks and its highest close since 31 August. The sequence is worth recording, because the obvious attribution is wrong: the stock opened flat at $63.07 against a $63.48 previous close, ran roughly 10% in the first thirty minutes to $70.28 by 10:00, then faded to $66.43 by 13:00 — before the Citi appearance began at 13:55 — and closed at $68.80 on heavy final-hour volume. The move was made in the opening half-hour, hours ahead of the only scheduled event of the day, and the stock actually fell through the appearance itself. It was not a sector move either: the semiconductor ETFs added 0.7% and 0.1%, and NXP, still the reported suitor, closed lower. No company announcement accompanied it — and a sixth of it came back the next session, −1.4% to $67.87 on 10 September, against a semiconductor index down 2.7%. On 11 September it did nothing at all, a single cent lower at $67.86, while the semiconductor index rose 1.8% — the one name on this page that joined neither the rare-earth selling nor the chip rebound. Then on 14 September the whole unexplained 9 September gain came back at once, −5.7% to $63.98, its worst session since 16 July and within fifty cents of the 8 September close it started from; 15 September then steadied it, +0.6% to $64.33 — before 16 September took it to $62.77, down 2.4%, its lowest close since 17 July. This time the attribution is easy and it is not about robots: public calls from several AI-lab executives for a slower pace of frontier development took the semiconductor complex down with them — SOXX −5.6%, Nvidia −3.4%, Broadcom −4.8%, AMD −4.4% — and Ambarella tracked the sector almost exactly. That is the useful fact about this position. On the way up, its 9 September move was idiosyncratic and unexplained; on the way down it was pure sector beta. That last session broke the pattern and was worth marking — the semiconductor index rose 0.6% on 16 September while Ambarella fell 2.4% — and then three sessions ran the other way just as hard: +6.6% to $66.91 on 17 September, the day after the Federal Reserve's first hike since 2023, −1.1% to $66.15 on 18 September, and +4.1% to $68.85 on 21 September with SOXX up 4.9% on AI optimism ahead of the 24 September state dinner — its highest close since 31 August. Three sessions, +9.7%, and again not a word from the company. It gave most of that back at once, −2.6% to $67.06 on 22 September, then steadied, +0.8% to $67.62 on 23 September — the only name on this page to rise on a session that took the whole minerals tier down — then added +3.3% to $69.86 on 24 September, and then +4.0% to $72.68 on 25 September, its highest close since 21 August. Neither had a company announcement attached, and the second is worth one line of method: the obvious candidate — the Developer Zone expansion on Google Cloud, with the Gemini Enterprise tooling, the ZEDEDA fleet integration and the Ultralytics YOLO collaboration — is dated 15 September 2026, seven sessions earlier, and aggregator write-ups published on the 25th that place it vaguely “in September” are how a stale release gets re-read as a same-day cause. The sector took about a quarter of it, SOXX +1.2%. Which settles the read on this position: down it was sector beta, up it is sector beta, and the robotics line inside it is doing none of the work in either direction. The next session took all of that back and then some. On 28 September Ambarella fell 5.5% to $68.68 against SOXX −2.1% and SMH −1.1% — again roughly three times the sector, again with nothing published by the company, and this time in the opposite direction, which is the cleanest possible confirmation of the read above: whatever is moving this position is not the robotics line and is not company news. 29 September then did nothing at all with it, +0.1% to $68.73 against a semiconductor complex up 1.2%, so the name-specific leg was neither extended nor taken back. That leaves Ambarella 2.7% lower over a month and 28.9% off its high, with a twelve-month column that fell seven and a half points on the 22 September session purely because the year-ago base rolled onto a +7.1% day, recovered to −12.9%, and now reads −17.0%. It remains the only tier-one name whose drawdown is set by the AI trade rather than by industrial demand. Ambarella is still the name closest to breaking robotics out, which would make it the cleanest read on real humanoid volume anywhere on this list — the next chance is Q3, in December.

The only vertically integrated Western play, and the one genuine bridge between "rare earths" and "robot actuators." Q2 2026 revenue of $108.5m (+89%) came with NdPr production of 840 tonnes (+41%) and sales of 1,006 tonnes — more than double the prior year — pushing adjusted EBITDA positive and narrowing the diluted loss to $0.11 from $0.19.

The government backstop is unusually deep: the Department of Defense took $400m of preferred stock in July 2025 to become the largest shareholder, with a ten-year $110/kg NdPr price floor, and has since signed a ten-year offtake for 100% of the output of the planned 10X facility in Northlake, Texas — a $1.25bn-plus campus commissioning from 2028 that is meant to lift MP's total US magnet capacity to roughly 10,000 tonnes a year, not to produce 10,000 tonnes on its own. Beijing noticed: China's Ministry of Commerce added MP to its export-control blacklist in June 2026, and the stock fell nearly 30% through July.

The 13 Aug earnings call surfaced a new line: a multi-year, nine-figure agreement signed in July to supply separated gadolinium oxide to an undisclosed US aerospace and defense manufacturer, recovered as a co-product of the existing Mountain Pass ore stream. Terms are undisclosed so it cannot be sized precisely, but it is the clearest evidence yet that MP is building toward a multi-element refinery rather than a single-product (NdPr) business.

WatchMagnetics segment revenue. At $16.5m against $95.6m from materials it is still the small half of the business — but it is the half that matters for anything robotic, and the only number here that scales with Western magnet independence. The tape went the other way meanwhile: a 5.5% fall to $51.32 on 10 September inside a broad metals liquidation, then a further 1.6% to $50.51 on 11 September against a rising market and a rising gold complex, then it paused — +0.3% to $50.68 on 14 September, one of only two tier-two names to hold a session that took REMX to a six-week low — then −3.0% on 15 September and −0.4% to $48.99 on 16 September, +0.8% to $49.38 on 17 September, −4.3% to $47.26 on 18 September — its lowest close since 3 August — then +5.8% to $50.00 on 21 September on the Greenland pact, its largest single gain in more than a month, and +2.1% to $51.04 on 22 September — before −4.2% to $48.89 on 23 September, its lowest close since 18 September — then a pause, +0.8% to $49.30 on 24 September, one of only two names on this tier to rise on a session that took REMX to its lowest close since 31 July, then −1.0% to $48.83 on 25 September on nothing at all. Those sessions tipped the year twice. The 22 September close put MP positive year to date by fifty-two cents against its $50.52 close of 2025; 23 September took it straight back under and it has gone further since. A company whose magnetics revenue nearly doubled over the year is back below square one in the price and has taken none of it back on its own account. The 23 September fall is worth separating: the dollar-led metals liquidation that day took the gold miners down 4.4%, so MP's 4.2% is roughly market beta — but it came alongside the Busan Agreement's extension to 10 January, which removes the November cliff edge that had been part of the scarcity bid. Two columns to read carefully either way. Three more sessions took it lower without a rare-earth headline in any of them: −4.9% to $46.45 on 28 September, its lowest close since 3 August, on the oil-and-rates repricing that hit the whole tier, and −2.2% to $45.43 on 29 September, a fresh low for the move, on a session when gold recovered 1.3% and REMX itself rose 0.5%. That last one is the cleanest statement of this card's argument: the fund that holds MP went up while MP went down two per cent. Year to date it is 10.1% lower and it remains 54.7% below its high, the widest that figure has been in this run. MP shows 19.1% lower over a month, much of which is a 30-day base that rolled up to 28 August's $56.13 rather than a weaker stock, and the twelve-month cell reads −33.4%. Read both against their own dates.

The source post is still wrong about the timeline, but this page was wrong about the other end of it, and the correction matters more. USAR did commission its Phase 1a commercial magnet line at Stillwater, Oklahoma in Q2 2026, pulling the plant forward by about two years from the 2028 date the post implies — and the company says it “has commenced commercial production.” What it has not done is sell any of it. The Q2 10-Q is explicit that Stillwater “has recently been commissioned and has commenced commercial production; however, we have not begun generating revenue from” sintered NdFeB magnets, and the 15 September risk-factor supplement goes further, describing Stillwater and Blacksburg as “under development and… not yet completed” with “no… revenues to date from the sale of neo magnets, critical minerals or rare earth minerals.” This page previously said USAR “began filling customer orders” in Q2 2026. It did not. Phase 1a is guided to a 600 mtpa run-rate by the end of Q4 2026 and 1,200 mtpa combined with Phase 1b in Q1 2027, against roughly 5,000 tonnes at full build — every one of those a target, none of them yet a shipment.

Q2 2026 revenue was $5.8m against a $10.3m net loss (down from $142.5m a year earlier, when the company had no commercial revenue at all). None of that $5.8m is magnets: the 10-Q attributes it “all” to Less Common Metals, the Cheshire metals subsidiary acquired in November 2025, and states that all revenue “is derived from sales of casting and strip casting” — at a gross loss of $1.6m on a negative 27.2% gross margin. The balance sheet is the actual headline: $1.53bn of cash at quarter-end, up from $359.9m at year-end 2025. USAR is deploying it into corporate structure as much as capacity — it closed the acquisition of Texas Mineral Resources Corp on 7 Aug, giving it outright ownership of Round Top, and finalized a roughly 13.6% stake in French rare-earth processor Carester. It agreed to buy Brazil's Serra Verde, the only scaled ex-China producer of all four magnet rare earths, for about $2.8bn; shareholders approved the share issuance on 28 August — 108,248,297 votes for against 1,403,269 opposed, with 16,879,393 abstentions — and the combination completed on 3 September 2026, announced the following morning and filed the same day on Form 8-K under Item 2.01. This page carried it as pending for a week longer than it was; that was wrong, and the correction is the more important half of this card.

What actually closed is bigger than the price tag suggested. USAR paid $300m in cash plus 126,849,307 new shares to Serra Verde's shareholders, lenders, warrant holders, employees and consultants, and took on Serra Verde's financing with it: a facility of up to $565m from the US International Development Finance Corporation, sized to fund the Brazilian optimisation and expansion programme through to positive cash flow. The Goiás operation has been producing since January 2024 and is finishing a commissioning and optimisation programme whose first stage targets a run-rate of about 4,000 tpa of total rare earth oxide by the end of 2026. Sir Mick Davis joins the board; Thras Moraitis becomes President immediately and succeeds Barbara Humpton as chief executive on 1 October. USAR now owns an operating heavy rare-earth mine, a magnet line and a separation stake — upstream, midstream and downstream in one company, which is what MP has and no one else outside China does.

The financing behind that deal landed on 24 August 2026 and is the most consequential development on this page since the last refresh. The special-purpose vehicle that will buy 100% of Serra Verde's Phase 1 output completed an upsized $1.55bn capitalisation: a $750m Department of War investment, raised from the $500m originally contemplated, a bank senior secured borrowing-base revolver of up to $500m, and a US government forward purchase contract for not less than $300m of rare-earth product over five years. The offtake runs fifteen years on take-or-pay terms with guaranteed price floors on the magnetic rare earths — including, on the company's account, the first such floors anywhere for dysprosium and terbium. Read against the $110/kg NdPr floor MP already has, Washington is now underwriting the price of the heavy elements too, which is the part of the chain China actually controls.

And on 9 September 2026 it broke ground on a second magnet plant, which this page should have carried a run earlier. The site is Blacksburg, South Carolina — 124 acres in Bailey Industrial Park, Cherokee County, about 800,000 square feet, roughly $1.2bn of investment and some 490 manufacturing jobs, commissioning in 2028. The capacity is the part that matters: 6,400 tpa of sintered NdFeB magnets plus 5,000 tpa of strip-cast metal and alloy. On its own that is larger than Stillwater's full build of roughly 5,000 tonnes, and it places a second and bigger magnet line behind the company's own metal. Measured against MP's 10X campus, which is meant to lift MP's total US magnet capacity to about 10,000 tpa from 2028, Blacksburg is the largest single increment to announced ex-China magnet tonnage anywhere on this page. The company says it screened nearly 275 sites before choosing it. None of this moved the stock, which fell 8.8% across the two sessions that followed.

The Round Top deposit in West Texas is the part that is genuinely years out, and the distinction matters: the magnets Stillwater is producing are made from purchased feedstock, not from USAR's own mine — and the 15 September supplement flags that too, warning that feedstock delays at Less Common Metals have already constrained the plant, and that China's 22 June 2026 export-control designation “has had and is expected to continue to have an adverse impact on our ability to source key raw materials.” Round Top did produce a first dysprosium oxide sample at 99.1% purity in January. Like MP, USAR was added to China's export-control list in June 2026. The stock sits 65.0% below its 52-week high, still the widest drawdown of the robotics-adjacent names, and closing the deal did nothing to lift it. It fell 5% on the day the SPV funding was announced, 6.5% on the day of the vote, 7.4% on 31 August when the result was disclosed and 3.1% on 1 September; it then drifted through six sessions either side of completion, fell 3.4% to $17.06 on 9 September, a further 6.0% to $16.04 on 10 September — the largest fall on the page that day, though that one arrived with the whole metals complex rather than alone — and 3.0% to $15.56 on 11 September, which did not: the complex rebounded that session and USAR made a fresh low regardless, its weakest close since 31 July. The one-way tape broke only briefly — +1.0% to $15.71 on 14 September, one of only two tier-two names to hold a session that took REMX to a six-week low, then −2.0% to $15.40 on 15 September and −1.9% to $15.10 on 16 September, a fresh low for the run. Then the move finally came, and not from the company: +3.5% to $15.63 on 17 September, −1.7% to $15.37 on 18 September, and +9.2% to $16.78 on 21 September — the largest single gain anywhere on this page in this period — on Trump's security agreement with Denmark and Greenland, followed by a much quieter +1.3% to $16.99 on 22 September — and then the whole policy bid came out at once, −6.8% to $15.83 on 23 September, the largest fall anywhere on this page that session and its lowest close since 18 September. That one is not market beta: the gold miners fell 4.4% and REMX 3.1% on the same dollar move, and USAR went half as far again as either, on the day Bessent extended the trade truce past its November expiry. The symmetry is the lesson — two sessions of policy bid on a treaty about an island it has no assets on, one session of policy unwind on a truce it is not party to either. USA Rare Earth owns nothing in Greenland and is not a signatory in Busan. A fourth session then took it lower again with no policy in it at all, −2.8% to $15.38 on 24 September, and the run has not stopped since: −1.3% to $15.18 on 25 September, −5.0% to $14.42 on 28 September on the oil-and-rates repricing, and −2.4% to $14.08 on 29 September, a fifth consecutive fall and its lowest close since 29 July, on a session when the benchmark that holds the tier closed higher. That leaves it 68.0% below its high, the steepest drawdown on the page bar Novonix. Six weeks of decisive corporate progress moved this stock down 21.8% over a month; policy headlines moved it nine per cent up and seven per cent down inside three sessions. Its twelve-month return reads −19.8%, three points lower than yesterday on a two-point session because the year-ago base rolled across a weekend, and the year to date is down to +18.3% from the +27.6% it carried a week ago. The market is pricing the dilution ahead of the assets — 126.8m new shares against 244.7m outstanding is arithmetic, the assets require execution — and pricing the policy tape ahead of both. The claim audit carries the Greenland attribution.

WatchThe first magnet invoice, which on the company's own account does not yet exist. Two run-rates are due by the end of this year — Stillwater's 600 mtpa of sintered magnets and Serra Verde's 4,000 tpa of rare earth oxide — and the gap between “commissioned” and “sold” is now the whole question. Every financing gate has been cleared — the vote, the $1.55bn SPV, the DFC facility — so from here the only thing left to miss is production, and the first management test is a leadership handover three weeks after the merger closed. The tape has read each corporate step as dilution arriving rather than risk lifting; the fourth-quarter numbers are where that gets settled either way.

Operationally the strongest of the five, and now with a full year on the board. FY26 results, reported 26 August 2026, were records across the line: revenue of A$977.9m, up 76%, net profit after tax of A$222.4m against A$8.0m the year before, REO production of 13,089 tonnes (+25%), NdPr production of 7,260 tonnes (+11%) and a record average realised price of A$80.7/kg. More strategically, it became the first commercial producer outside China of separated dysprosium and terbium — first terbium oxide in June 2026, on a heavy rare-earth circuit of about 1,500 tonnes a year.

The market did not take it as a clean beat. The ADR fell 5.9% on results day before recovering 5.0% the next session, then gave back another 8% into 1 September with the rest of the mining complex, and rose in four sessions to $11.23 on 8 September. That run ended abruptly: −2.9% to $10.91 on 9 September, then −4.3% to $10.44 on 10 September in the broad metals selloff, −2.2% to $10.21 on 11 September after it reversed, −3.2% on 14 September, −0.7% on 15 September and −2.9% to $9.53 on 16 September — its lowest close since 6 January. It has since recovered the handle: +2.5% to $9.77 on 17 September, +2.9% to $10.05 on 18 September, its first close back above $10 since 11 September, then the one faller on the page's Greenland session, −0.3% to $10.02, then the tier's second-strongest session the next day, +3.1% to $10.33 on 22 September, and then −2.6% to $10.06 on 23 September in the dollar-led liquidation. Nothing from the company behind any of them, in either direction; the Sydney ordinary line followed a session later, −1.9% to A$14.39 on 24 September, in an Asian rare-earth session the wires attributed to the truce extension. Over a month the ADR is 16.6% lower against REMX's 16.3% — and that ordering, which had flipped for a week, has flipped back: the single name is falling marginally faster than the fund again, which is what a 0.62 correlation and a higher beta ordinarily produce. A fifth session followed, −1.2% to $9.94 on 24 September, its lowest close since 17 September and its first below $10 since then. Its twelve-month column crossed below zero on 23 September, from +1.0% to −8.1%, the year-ago base moving up from $10.23 to $10.95 doing most of that, and it now reads −14.4%. Three more falls have taken it lower still — −3.8% to $9.58 on 28 September and −1.0% to $9.48 on 29 September, its lowest close since 6 January 2026, on a session when the benchmark that holds it closed higher — while the Sydney ordinary line went the other way a day later, +1.4% to A$13.83 on 30 September. Nothing from the company behind any of it. The reason is on the cost side: capital expenditure on the heavy rare-earth circuit has escalated 63%, to A$294m from A$180m, which the company attributes to sourcing equipment outside China. That is the price of the scarcity premium, stated in cash.

That heavy-element capability is the real scarcity. Terbium oxide outside China has traded at $4,500–$4,700/kg against under $1,000 domestically, and dysprosium and terbium are what keep magnets stable at motor operating temperatures. The post's claim that Lynas is "now building a US processing facility" is out of date: on 16 March 2026 the US government redirected the US$96m earmarked for the Seadrift, Texas heavy rare-earth plant into a four-year purchase agreement for Lynas product instead, with a US$110/kg NdPr floor. The Texas plant is in limbo, not under construction.

WatchWhether Seadrift is revived or quietly shelved, and the dysprosium/terbium ramp against that 63% capex escalation. The heavy circuit is the part China cannot easily replace and the part no one else outside China has — but USA Rare Earth's new US-backed Dy/Tb price floors are the first sign that someone else intends to be paid for it too. A permanent CEO is also still outstanding: Pol Le Roux has run the company on an interim basis since 1 July.

A well-financed critical-minerals project that has almost nothing to do with robotics. Perpetua secured a $2.9bn EXIM loan, board-approved in May 2026 and expected to become available in the second half of the year, on top of a $255m private placement in October 2025 backed by Agnico Eagle and JPMorgan. Construction at Stibnite in Idaho is underway.

Two caveats the post skips. First, this is predominantly a gold mine: reserves of roughly 4.8 million ounces and about 450,000 ounces of gold a year over the first four years, with antimony supplying an estimated 35% of US demand alongside it. Second, production does not begin until 2029. Antimony goes into flame retardants, ammunition and alloys — not robot joints. It earns its place on a critical-minerals list, not on a robotics one.

The tape adds a third caveat, and fifteen sessions have now sharpened it in both directions. Perpetua shows −13.1% over the past month, and that relationship inverted for a week before reasserting itself: bullion is 7.6% lower over the same 30 days and the gold miners 11.8% lower, so a 13.1% fall now sits above both — a mild amplification of the equities rather than of the metal, which is the ordinary configuration for a high-beta gold miner. The explanation is in the sessions below: several of them moved on something other than gold. On 31 August gold rose and Perpetua fell 4.7% anyway, alongside the gold miners; on 1 September gold fell 1.9%, the miners 3.9%, and Perpetua 5.8%. Then it ran in reverse: on 2 September the miners rose 3.1% and Perpetua 4.1%. On 3 September the relationship held in direction but not in size — gold 1.9%, the miners 4.0%, and Perpetua only 2.4%, for once lagging the equities it usually amplifies. Then on 4 September it decoupled altogether: gold fell 1.4% and the miners 2.2%, and Perpetua did nothing at all, +0.2% to $25.09. On 8 September the usual relationship resumed quietly: gold eased 0.8% and Perpetua 1.3% to $24.76. On 9 September it went missing again: bullion added 0.9% and the gold miners 1.1%, and Perpetua closed unchanged at $24.76, to the cent. Then on 10 September it came back with force — bullion −1.7%, the gold miners −3.5% and Perpetua −4.4% to $23.67. On 11 September it went quiet once more: bullion rose 0.6% and the miners 1.1%, and Perpetua eased 0.2% to $23.63, its lowest close since 1 September and the only tier-two name that barely moved on a day the rest of the tier fell. Then on 14 September it amplified the complex again and harder than either leg of it: bullion −1.3%, the gold miners −3.1%, and Perpetua −4.6% to $22.55, its lowest close since 4 August — before it recovered 0.6% to $22.69 on 15 September, the only tier-two name to rise on a session when gold fell again. The three sessions since split the same way. On 17 September it tracked the equities closely — the miners +3.4%, Perpetua +3.8% to $23.37 — and on 18 September it tracked them again, the miners −0.5% and Perpetua −0.6% to $23.24. Then on 21 September it decoupled upward for the first time in this run on something that was not gold at all: bullion −0.7%, the gold miners −1.1%, and Perpetua +1.9% to $23.68, moving with the rare-earth complex on the Greenland pact rather than with the metal it is actually levered to. On 22 September it went back to the miners and amplified them mildly: bullion +0.4%, the gold miners +3.6%, and Perpetua +4.6% to $24.76 — the largest single gain anywhere on this page that session, and still an ordinary gold-equity beta rather than an antimony event, with no company disclosure attached to it. That is the exception that proves the rule this card exists to state — antimony is a critical mineral, so it catches a critical-minerals bid, and none of that is the gold mine that will supply 450,000 ounces a year from 2029. Four times in thirteen sessions it has ignored a moving metal and a moving miners index, and twice it has multiplied one. That session carries a caution worth recording, because this page names GOLD as the instrument to check before attributing a Perpetua move. GOLD is Barrick, and Barrick rose 11.2% that day against a falling metal and a falling miners index. A single-name divergence that wide is company-specific, not a gold signal — which is why the comparison above is drawn against the miners index rather than against Barrick alone. Then 23 September put it back in its ordinary place and took the year with it: bullion −1.8%, the gold miners −4.4%, and Perpetua −5.8% to $23.32, its lowest close since 18 September — a mild amplification of the miners in a dollar-led liquidation, with no antimony in it and no company disclosure, exactly as on the way up the session before. Its year-to-date column crossed back below zero in the process, from +2.3% to −3.7%, one session after crossing above. Then 24 September broke the pattern in the one direction it had not yet gone: Perpetua rose 0.4% to $23.42 while the gold miners fell 1.3% and bullion 0.3% — the first session in this run where it outperformed gold rather than amplifying it, and again on no company disclosure. Then 25 September put it straight back in line and lagging slightly: the gold miners rose 0.6%, bullion 0.4%, and Perpetua 0.3% to $23.49. Then 28 September delivered the largest single fall this page has recorded on any name this run, and it was still the same relationship: −7.1% to $21.82, its lowest close since 4 August, against gold miners −5.4% and bullion −3.9% — an amplification of the equities, on a session whose cause was an oil price and a rates repricing rather than anything in the ground. Brent went back toward $106 after the White House rejected Iran's proposal to reopen the Strait of Hormuz, the ten-year Treasury yield passed 5.2%, and gold had its sharpest fall in this run. Not one part of that chain is antimony, and no company disclosure accompanied it. Across eighteen sessions Perpetua tracked the mining equities, not the metal, and one session of mild outperformance does not change that. The exposure is to gold equities, not to gold. Then 29 September made the point from the other side: Perpetua fell 1.3% to $21.53, its lowest close since 4 August, on a session when bullion rose 1.3% and the gold miners rose 1.3% — the first time in this run the name has gone the opposite way to the equities it normally amplifies, and again with nothing published. Eighteen sessions of tracking the miners, one of tracking nothing. Its year to date now reads −11.1% and the drawdown 42.4%, and its twelve-month cell fell from +23.6% to +3.1% on 28 September — twenty points, almost none of it price, because the year-ago base rolled onto a day 11.4% higher — before recovering to +4.5% as that base rolled back down. Antimony went nowhere throughout: $51.80/kg at the 18 September assessment, down 5.85% year to date and about 43% from a year earlier. The commodity that earns this name its place on a critical-minerals list is flat to falling either way.

WatchFinancial close on the EXIM facility, still guided to the second half of 2026 as of the 17 August quarterly and not yet done. Approved is not drawn — and with first metal four years out, financing terms matter more than commodity prices here. Cash at 30 June was $574.2m.

The weakest name on either list, and it deserves a plain warning rather than a bullet point. Novonix makes synthetic graphite for battery anodes in Chattanooga, Tennessee — a battery input, not a magnet input, and not part of any robot's bill of materials in the way the tier-one components are.

The financials are severe, and on 31 August 2026 the auditor said so in the accounts. The half-year report for the six months to 30 June shows a loss of $24.6m against $20.1m a year earlier, net operating cash outflows of $23.1m, and cash down to $59.5m from $79.9m at 31 December. Net current liabilities stand at $2.5m where six months earlier there were net current assets of $5.6m. The independent auditor's review report carries a material uncertainty that may cast significant doubt on the group's ability to continue as a going concern. The same report has the company backing away from a land purchase beside its Chattanooga plant and stretching the Riverside ramp-up, which is what conserving cash looks like in a capital project. The genuine positive is still the US$103m of 48C tax credits certified in April 2026 for the Riverside project — but those vest only when the first 11,000 tpa of capacity is in service before 7 April 2028, and a slower ramp is the one thing that deadline cannot absorb. Mass production for lead customer Panasonic is not expected before 2027.

The going-concern note names the trigger, which is what makes this more than a slow burn. $35m of face value in unsecured convertible debentures issued to Yorkville carries an A$0.12 floor on the ASX share price: a fall below it may constitute an amortisation event, under which the company could be required to redeem part or all of the outstanding balance in cash. On 31 August, the day that note was published, the ordinary shares closed at A$0.11, down 12.0% on 12.3m shares against a recent average nearer 3.5m, and the Nasdaq line fell 12.3% the same session. They have not recovered: A$0.11 on 1 September, A$0.105 on 2 and 3 September, A$0.11 on 4 September, A$0.105 on 7 September, then −9.5% to A$0.095 on 8 September — the first close below ten cents — A$0.098 on 9 September, a 7.1% bounce to A$0.105 on 10 September on 10.8m shares against a recent average nearer 3.5m, and A$0.105 again on 11 September — ten consecutive closes below the floor, the lowest of them 20.8% under it. Then on 14 September the shares rose 14.3% to A$0.12 on 7.0m shares, their first close back at the threshold since 28 August, with no ASX announcement attached to it. That was the top. Three sessions at A$0.11 followed, then A$0.10 on 18 September on 23.2m shares — by far the heaviest volume of this entire run, against a recent average nearer 3.5m — A$0.099 on both 21 and 22 September, A$0.097 on 23 September, a fresh low for the run, and A$0.099 on 24 September. The clause turns on a fall below A$0.12: the shares have now closed below it in eight consecutive sessions since touching it, the last of them 17.5% under it, and the heaviest volume of the run came on the way down. They are also 38% below the A$0.16 the June placement was struck at. Nothing has been announced. This is the position the going-concern note describes, arrived at. The directors rest the going-concern basis on a history of raising capital, including $14.5m from a June 2026 placement; the share purchase plan that followed it raised A$0.96m.

The US listing is a separate problem, already solved once. On 12 August the company agreed with BNY to change its ADS ratio from one ADS per four ordinary shares to one per forty — economically a one-for-ten reverse split of the ADSs, effective 27 August 2026, done to lift the traded price back over Nasdaq's minimum bid threshold. The underlying ASX ordinary shares are untouched; only the US wrapper changed. On the new ratio the US line fell to $2.86 on 3 September, rebounded 5.2% to $3.01 on 4 September, fell 8.3% to $2.76 after Labor Day, eased 0.7% to $2.74 on 9 September — a two-year closing low — then rose 6.2% to $2.91 on 10 September, the only US line on this page to rise that session and a day behind the Australian bounce it was following, added a further 2.4% to $2.98 on 11 September, and then jumped 8.4% to $3.23 on 14 September — its highest close since 28 August and the largest single gain anywhere on this page that session — before handing most of it back, −5.6% to $3.05 on 15 September. Since then it has followed the Australian line down with a session's lag and no news at either end: $2.97 on 16 September, $3.03 on 17 September, −4.8% to $2.885 on 18 September, −1.6% to $2.84 on 21 September, a near-flat $2.85 on 22 September, −3.4% to $2.801 on 23 September and then −5.7% to $2.64 on 24 September — its worst session since 8 September and the lowest close in its three-year series, taking out the $2.74 of 9 September that had been the floor. The 52-week low proper is $2.52, an intraday print rather than a settlement. The Sydney line, a session ahead, closed A$0.098 on 25 September — a ninth consecutive close below the A$0.12 Yorkville amortisation threshold, 18% under it, and 39% below the A$0.16 the June placement was struck at, with no announcement attached to any of it. It then steadied: +1.5% to $2.68 on 25 September and +0.4% to $2.69 on 28 September, the only riser in the whole minerals tier on a day the rest of it was sold off. That leaves the US line 93.1% below its high, 81.2% down over a year — three points of that arriving on a 0.7% session as the year-ago base rolled up 16.4% across a weekend, not on the price — and 73.6% lower year to date — still the worst figures in every column on this page, and improved in three of them only because the lookback bases rolled off a crash rather than because the price recovered. A ratio change buys compliance, not solvency: in the twenty-two sessions since it took effect the US line has gone from $3.51 to $2.69, still clear of Nasdaq’s $1 threshold but well inside the range where it matters.

WatchWhether the A$0.12 floor being breached is now treated as an amortisation event. The shares touched the level exactly on 14 September and have closed below it in every one of the twelve sessions since, ending at A$0.097 on 30 September, 19% under it, with the heaviest volume of the run on the way down. That is no longer an open question about whether the threshold gets tested; what is open is the consequence, and a cash redemption against a $59.5m balance falling by roughly $23m a half is a large one. Dilution or a raise was already the base case; the auditor has written the reason into the accounts and the tape has now written the trigger. It is the only name on this list where solvency is the question rather than growth.

The most substantial magnet business you can actually buy. TDK is the largest non-Chinese neodymium magnet manufacturer by revenue and the most globally diversified, producing sintered NdFeB in Japan and China alongside ferrite and metal-powder products. The company's origins are literally magnetic — it was founded in 1935 to commercialise ferrite.

Two honest caveats. Magnets are a modest slice of the group: TDK is dominated by its energy business, including ATL, one of the world's largest lithium battery makers, plus passive components and HDD heads. And its 0.53 correlation to the robotics basket — the highest of any name outside tier one, above every robotics ETF tested — largely reflects its status as a large Japanese electronics exporter moving with the same market, not humanoid demand reaching its P&L. You would be buying a battery-and-components group with a major magnet business attached.

WatchAny segment disclosure sizing magnets against the battery business. Without it, the magnet exposure is real but unmeasurable — the same problem Aichi Steel has, at much larger scale. The 0.53 correlation keeps earning its keep: TDK fell 6.9% on 8 September — the worst session of any name on this page — in a yen-driven selloff that had nothing to do with magnets, recovered 1.4% and a further 1.4% to ¥2,850.5 by 10 September, gave back 1.5% on 11 September as oil and bond yields took the whole Tokyo market down, added 0.3% on 14 September while the index fell 0.81% on its AI complex, rose a further 0.6% on 15 September and added 1.4% to ¥2,872 on 16 September, before giving all of it back and more on 17 September, −2.3% to ¥2,806 — one of only two Tokyo names on this page to fall on a rising index — then recovering +1.4% to ¥2,845 on the Bank of Japan's hike, the smallest of the five Tokyo gains that session — and then, on the reopen after the three-day holiday, the largest: +3.9% to ¥2,954.5 on 24 September, the biggest single gain anywhere on this page that day, on a session led by the semiconductor-equipment names rather than by anything magnetic. It added +0.8% to ¥2,978 on 25 September, its highest close since 7 September — though the index rose 1.30% that day, so this was a lag rather than a lead — and gave a little back on 28 September, −0.8% to ¥2,955, roughly with an index down 0.73%. It moves with Murata and Taiyo Yuden rather than with the gearbox makers, which is the point: this is a Japanese electronics exporter that happens to make magnets. Note what it did not do on 14 September: the AI-pace selloff that took the US semiconductor complex down more than 5% that session left TDK higher on both sides of it. A passive-components maker is not an AI-silicon name, and the tape agrees even when the sector label does not. It eased again on 29 September, −1.2% to ¥2,919, against an index down 0.60%, then took it back on the quarter's last day, +2.1% to ¥2,981 on 30 September, its highest close since 1 September — and on an index up 1.94% that is a lag again, which is the shape this name keeps making. Down 3.2% over a month, where a fortnight ago that figure was 10.6%, with a twelve-month return of +38.8% that has swung between +32% and +51% inside a month, purely on which day the lookback base lands — and which gained seven points on the reopen alone, as the holiday rolled its base six days onto a lower one. The same calendar effect this page keeps flagging in Nidec's and Harmonic's columns.

The cleanest direct way to own a magnet maker on this list. A Toyota Group company engineering permanent magnets tuned for robotic actuators, with an explicit design goal of reducing dependence on constrained rare earths — the same strategic bet Proterial and Niron are making, but in a listed vehicle.

It is also the steadiest chart in this report: up 12.8% over a year and 13.5% below its 52-week high — now the tightest drawdown on the page, Nidec having vacated that position by falling twenty points in two sessions — against 28–45% for four of the six tier-one names. That is partly a virtue and partly a warning: magnets are a modest slice of a diversified steelmaker, so the humanoid narrative barely moves it in either direction, up or down. It sat out the 4 September rally with a 0.8% fall, sat out Monday's 2.1% index rally with a 0.2% fall, and lost 1.8% on 8 September on a day the component names lost 3–7%. What it had not sat out was the drift: four consecutive falls, ending −0.8% to ¥3,115 on 10 September, on a day Harmonic Drive rose 2.7% and Nidec 5.6%. Then it did the rarest thing on the page — on 11 September it closed unchanged at ¥3,115, to the yen, while the Nikkei fell 1.93% and every other Tokyo name here lost ground. On 14 September it added 0.3% to ¥3,125, its first rise since 3 September, on a day the index fell again, added 0.8% on 15 September, 1.3% to ¥3,190 on 16 September and a further 2.7% to ¥3,275 on 17 September — four consecutive gains and its highest close since 3 September — before doing the one genuinely contrary thing on the page: −1.4% to ¥3,230 on 18 September, the only Tokyo name here to fall on the Bank of Japan's hike, on a session when the index rose 1.38% and the gearbox makers rose 0.8–4.8%. Then it did the contrary thing again from the other side: on the 24 September reopen it closed unchanged at ¥3,230, to the yen, while the index rose 0.76% and every other Tokyo name on this page moved 1.2–3.9%. It repeated the trick on 25 September, −0.2% to ¥3,225 against an index up 1.30% — two consecutive sessions of doing almost nothing while Tokyo moved two points. Its four-week column is now 0.0%, flat to the yen against a 26 August base of ¥3,225. Steadiness cuts both ways. It sat out the drawdown and it has now sat out three rallies, which is exactly what a magnet line inside a diversified steelmaker should be expected to do — and it is why this name will not tell you anything about humanoid demand in either direction.

One caution attaches to the figures above, because the largest session this card has recorded was not a market judgement. On 29 September 2026 the shares fell 3.9% to ¥3,080 — the worst of the six Tokyo names that day — and they went ex-dividend the same morning, ¥75.00 a share, payable 26 November. On the ¥3,205 previous close the distribution is 2.3 points of that 3.9%, leaving about 1.6% of actual repricing, and nothing was disclosed by the company. Both the year-to-date cell and the drawdown widen on the ex-date for the same mechanical reason. It is the dividend version of the base-roll problem this page flags elsewhere: a column can move several points because of a corporate action, and a reader comparing it with yesterday's is comparing two different things. The following session removes the excuse, though, and it is the reason the caution does not end there. 30 September took it a further 1.3% to ¥3,040, its lowest close since 31 July, on a day the Nikkei rose 1.94% and every other Tokyo name on this page went with it. Three points of relative ground on a session with no dividend in it and nothing disclosed is the only part of the two-day fall that is a market judgement, and it is the part worth watching.

WatchAny disclosure sizing the magnet business separately from steel. Without it you are buying a steelmaker with a magnet option attached, and the option is not priced because it is not visible.

A real magnet business you cannot buy directly. Arnold makes permanent magnets, precision thin metals and magnetic assemblies to the tolerances robotics OEMs need — and in March 2026 signed a distribution agreement with USA Rare Earth, linking it straight to tier two. But it has been a subsidiary of Compass Diversified since a $130.5m acquisition in 2012, and CODI is the only way in.

That is a poor trade for magnet exposure, and the reason is not subtle. CODI is a diversified holding company whose stock fell 59% in May 2025 when a probe found pervasive accounting fraud at its Lugano Diamonds unit. It restated fiscal 2022–2024, deconsolidated Lugano after a Chapter 11 filing in November 2025, triggered credit-facility defaults requiring forbearance, and suspended its distributions. The stock is up 133.3% year to date because it is recovering from that hole, not because of magnets — and it fell 2.7% on 9 September and a further 2.3% to $10.96 on 10 September, its lowest close since 6 August, in a session that had nothing to do with either magnets or diamonds. It has since gone nowhere with unusual precision: +0.5%, +2.7% to $11.31, −1.9%, −0.8%, +0.6%, −0.5%, +1.6% to $11.21 on 21 September, +1.1% to $11.33 on 22 September, +0.2% to $11.35 on 23 September — the only US name on this page besides Ambarella to rise on a day the minerals tier was liquidated — −0.9% to $11.25 on 24 September, unchanged at $11.25 on 25 September, −0.4% to $11.20 on 28 September — one of only two US names on this page to fall less than a point on a day the minerals tier was sold off wholesale — and −1.4% to $11.04 on 29 September, its largest fall of the sequence and its lowest close since 18 September, on a session when the metals complex recovered. That is thirteen sessions inside thirty-five cents, eight cents above the 10 September low they started from. Nothing about Arnold changed in either direction across any of them, which is the recurring problem with owning a magnet business this way: the only listed route to it is a holding company whose price is set by its own recovery.

The Q2 2026 call, held 17 Aug, is the freshest read on Arnold specifically. Subsidiary adjusted EBITDA came in at $91.5m (+12.6% year over year), helped by the 1 May sale of the Sterno food-service business, whose proceeds (over $280m) went straight to paying down the senior secured term loan — total debt fell to $1.59bn from $1.89bn at year-end 2025. COO Zach Sawtelle, who succeeds retiring CEO Elias Sabo at the end of 2026, called Arnold's segment "a standout, up nearly 50%," with a strong backlog tied to non-China rare-earth magnet sourcing and progress at a Thailand facility. Management said it is still pursuing further divestitures to cut debt, but did not name Arnold as a candidate — if anything, a segment growing 50% is the one they would want to keep. CODI shares still fell 4.8% on the day.

WatchWhether CODI divests Arnold. Management's 17 Aug commentary points the other way for now — Arnold was singled out as a growth standout, not flagged among the divestiture candidates — but a holding company still repairing its balance sheet post-Lugano remains a seller in waiting.

Not investable, but the most strategically interesting name in this section — because it is trying to make the bottleneck irrelevant rather than relieve it. Niron's iron nitride permanent magnets, out of University of Minnesota research, use no rare earths at all. If they work at scale, the entire NdPr supply argument underpinning tier two weakens.

It just got a serious endorsement: on 7 August 2026 the Department of War's Office of Strategic Capital issued a conditional commitment for a direct loan of up to $150m over 20 years for a 287,000 sq ft plant in Sartell, Minnesota — intended as the world's first full-scale iron nitride production site, targeted at robots, defence systems and electric motors. The same release names a second $150m loan from the Shakopee Mdewakanton Sioux Community for the same site, so the plant carries up to $300m of committed debt against roughly $50m of venture capital raised to date.

Construction reached a visible milestone on 10 September 2026: Niron raised first steel at Sartell and, in the same release, disclosed an equity investment from Honda, made through Honda Xcelerator Ventures on undisclosed terms. That is the part worth marking. Every dollar behind this company so far has come from venture funds or from government — the Department of War loan, the tribal loan. An automaker putting its own balance sheet into rare-earth-free magnets is a customer-side endorsement, and customers are the constituency whose behaviour would actually reprice tier two.

The number that matters for tier two is the capacity. Sartell is scoped at up to 1,500 tonnes a year of rare-earth-free permanent magnets, operational in 2027 — small against MP's planned ~10,000 tonnes, but Niron says a follow-on 10,000 tonne US plant breaks ground in 2028, with site selection already under way. If the second plant lands on schedule, the rare-earth-free capacity arriving at the end of this decade is the same order of magnitude as the Western NdFeB capacity being subsidised into existence today.

WatchSartell's commissioning, still pointed at 2027 now that the structure is going up, whether the 10,000-tonne follow-on site is actually named, and whether any other original-equipment maker follows Honda in. Track it as a threat to the tier-two thesis rather than as a position — the first credible rare-earth-free magnet at volume reprices every name in that tier downward.

Proterial — formerly Hitachi Metals, a genuine heavyweight in advanced magnetic materials and rare-earth-free development — has not been buyable since October 2022, when a Bain Capital-led consortium completed a roughly $7.5bn take-private and the shares were delisted. It was renamed in January 2023. Any list presenting it as a way to invest in magnets is out of date by nearly four years.

Noveon Magnetics is a private Texas manufacturer producing sintered NdFeB through its EcoFlux recycling process — a closed-loop route that sidesteps mining entirely. It has raised a $75m Series B and is operational, which makes it a real competitor to MP and USAR, just not a tradeable one.

On the Chinese side, the incumbents are what make the ~90% midstream share real. Two names circulating in research summaries, Ningbo Zhanhao and Mainrich Magnets, could not be verified as listed entities and should not be treated as tickers. The clearest listed Chinese pure-play in rare-earth permanent magnets is Ningbo Yunsheng (600366.SS) — A-share access and Chinese policy risk apply, which is much of the reason the West is building alternatives at all.

WatchConsolidation. A Western magnet maker being acquired, floated or spun out is the most likely route by which this layer becomes investable at all — and every name here is a candidate.